Department of Neurosurgery, Lenox Hill Hospital, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New York, NY, USA.
Department of Neurosurgery, Lenox Hill Hospital, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New York, NY, USA.
Clin Neurol Neurosurg. 2020 Aug;195:106075. doi: 10.1016/j.clineuro.2020.106075. Epub 2020 Jul 7.
Neuro-oncological research is at the forefront of the rising cancer therapy market, as evidenced by its growing revenue and the multitude of clinical trials investigating innovative treatment approaches. The Feinstein Institute for Medical Research, in conjunction with the Department of Neurosurgery at Lenox Hill Hospital and the Zucker School of Medicine at Hofstra / Northwell, sponsored The Brain Tumor Biotech Summit in New York City in June 2019. The aim of the Summit was to provide a forum that encourages collaboration between cancer specialists, biotechnology and pharmaceutical industry leaders, and the investment community in order to promote innovation and advance emerging therapies for brain tumors. Areas highlighted during the Summit included immunotherapy, precision medicine, and novel applications and experimental treatments such as receptor targeting, methods for improved drug delivery, and innovative intraoperative techniques and technologies. This review synthesizes the recent breakthroughs in brain tumor research as presented at The Brain Tumor Biotech Summit.
神经肿瘤学研究处于癌症治疗市场兴起的前沿，其不断增长的收入和大量临床试验表明了这一点，这些试验正在探索创新的治疗方法。费恩斯坦医学研究所与莱诺克斯山医院神经外科以及霍夫斯特拉/北岸大学扎克医学院合作，于 2019 年 6 月在纽约市举办了脑肿瘤生物技术峰会。峰会的目的是提供一个论坛，鼓励癌症专家、生物技术和制药行业领导者以及投资界之间的合作，以促进创新并推进脑肿瘤的新兴疗法。峰会期间强调的领域包括免疫疗法、精准医学以及新型应用和实验治疗，如受体靶向、改进药物输送的方法以及创新的术中技术和技术。本文综述了在脑肿瘤生物技术峰会上展示的脑肿瘤研究的最新突破。
